Alcon Inc. (SWX: ALC)

Market Cap	39.30B
Revenue (ttm)	8.25B
Net Income (ttm)	980.71M
Shares Out	494.60M
EPS (ttm)	1.98
PE Ratio	40.21
Forward PE	27.37
Dividend	0.24 (0.31%)
Ex-Dividend Date	May 14, 2024

Volume	866,116
Average Volume	696,800
Open	78.08
Previous Close	77.98
Day's Range	78.02 - 79.70
52-Week Range	64.32 - 85.34
Beta	0.74
RSI	58.29
Earnings Date	Feb 27, 2025

About Alcon

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company’s Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic mi...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1945
• Employees: 25,315
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: ALC

Financial Performance

In 2023, Alcon's revenue was $9.46 billion, an increase of 8.47% compared to the previous year's $8.72 billion. Earnings were $974.00 million, an increase of 190.75%.

Financial numbers in USD